The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form - Global" category.
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
A mid-size pharmaceutical company based in the United States (US) and Europe (EU) was developing a COVID-19 vaccine using a prioritized protocol with an extremely aggressive timeline. In the race to develop a successful vaccine, they needed a partner that had the network, capabilities, and expertise to coordinate all project activities and provide solutions to get to market faster and more importantly, further accelerate the speed of providing product to the patient.
Download the case study to learn more.